Disclosure Panels Details Page
Breast Cancer Panel - Disclosures as of 07/20/2014
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Benjamin Anderson MD | None | None | AstraZeneca Pharmaceuticals LP | None | ✔ |
| Ron Balassanian MD | None | None | None | None | ✔ |
| Sarah Blair MD | None | Medtronic, Inc. | None | None | ✔ |
| Harold Burstein MD, PhD | None | None | None | None | ✔ |
| Amy Cyr MD | None | None | None | None | ✔ |
| Anthony Elias MD | Astellas Pharma US, Inc. CytRx Genentech, Inc. Incyte Medivation NeuVax |
Genentech, Inc. | None | None | ✔ |
| William Farrar MD | None | None | None | None | - |
| Fayna Ferkle PharmD | None | None | None | None | ✔ |
| Andres Forero-Torres MD | Abbott Laboratories BioCryst Biogen Idec Celgene Corporation Daiichi- Sankyo Co. Eisai Inc. Eli Lilly and Company Genentech, Inc. GSK Immunomedics Pfizer Inc. Seattle Genetics |
None | Seattle Genetics | None | ✔ |
| Lauren Gallagher | None | None | None | None | ✔ |
| Sharon Giordano MD, MPH | None | None | None | None | ✔ |
| Lori Goldstein MD | Dompe Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. |
None | Novartis Pharmaceuticals Corporation Synta Pharmaceuticals Corp. |
None | ✔ |
| William Gradishar MD | None | Amgen Inc. Eisai Inc. Genentech, Inc. |
None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Daniel Hayes MD | Janssen Pharmaceuticals | Inbiomotion Oncimmune |
None | None | - |
| Clifford Hudis MD, FACP, FASCO | Alliance I-SPY2 |
None | None | ASCO|Breast Cancer Research Foundation | ✔ |
| Steven Isakoff MD, PhD | Abbott Laboratories Bayer HealthCare Exelixis Inc. Genentech, Inc. Merrimack Pharmaceuticals Pharmamar |
BIND Therapeutics Merrimack Pharmaceuticals |
None | None | ✔ |
| Rashmi Kumar PhD | None | None | None | None | ✔ |
| P. Kelly Marcom MD | Abbott Laboratories Veridex, LLC |
None | None | None | ✔ |
| Ingrid Mayer MD, MSCI | Novartis Pharmaceuticals Corporation | Genentech, Inc. Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Joan McClure MS | None | None | None | None | ✔ |
| Beryl McCormick MD | None | None | None | None | ✔ |
| Robert Miller MD | None | None | None | None | ✔ |
| Sameer Patel MD, FACS | None | None | None | None | ✔ |
| Lori Pierce MD | None | None | None | UpToDate | - |
| Elizabeth Reed MD | Agendia BV Novartis Pharmaceuticals Corporation |
UnitedHealthcare | None | None | ✔ |
| Kilian Salerno MD | None | None | None | None | ✔ |
| Lee Schwartzberg MD, FACP | Bristol Myers Squibb Eisai Inc. |
Amgen Inc. Eisai Inc. Genentech, Inc. GSK |
Amgen Inc. Bristol Myers Squibb Genentech, Inc. GSK |
None | ✔ |
| Dottie Shead MS | None | None | None | None | ✔ |
| Mary Lou Smith MBA, JD | Genentech, Inc. | None | None | Gateway for Cancer Research Foundation|National Accreditation Program for Breast Centers | ✔ |
| Hatem Soliman MD | Agendia BV Amgen Inc. Genentech, Inc. Novartis Pharmaceuticals Corporation |
Etubics | Celgene Corporation | None | ✔ |
| George Somlo MD | National Cancer Institute | Abraxane Celgene Corporation Genentech, Inc. Millennium Pharmaceuticals, Inc. Roche Laboratories, Inc. |
Celgene Corporation Millennium Pharmaceuticals, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. sanofi-aventis U.S. |
None | ✔ |
| Melinda Telli MD | Abbott Laboratories Calithera Novartis Pharmaceuticals Corporation PharmaMar sanofi-aventis U.S. |
Oncoplex DX | None | None | ✔ |
| John Ward MD | Galena Biopharma | None | None | None | ✔ |
| Richard Zellars MD, MBA | None | None | None | None | ✔ |